These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12812337)
1. Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis. Amato VS; Andrade HF; Amato Neto V; Duarte MI Am J Trop Med Hyg; 2003 May; 68(5):527-8. PubMed ID: 12812337 [TBL] [Abstract][Full Text] [Related]
2. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Amato VS; de Andrade HF; Duarte MI Acta Trop; 2003 Jan; 85(1):39-49. PubMed ID: 12505182 [TBL] [Abstract][Full Text] [Related]
3. In Situ Cellular Response Underlying Successful Treatment of Mucosal Leishmaniasis with a Combination of Pentavalent Antimonial and Pentoxifylline. Faria DR; Barbieri LC; Koh CC; Machado PRL; Barreto CC; Lima CMF; Lessa MM; Carvalho E; Gollob KJ; Dutra WO Am J Trop Med Hyg; 2019 Aug; 101(2):392-401. PubMed ID: 31219000 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of the mucosal lesion in mucocutaneous leishmaniasis. Esterre P; Guerret S; Ravisse P; Dimier-David L; Dedet JP; Grimaud JA Parasite; 1994 Dec; 1(4):305-9. PubMed ID: 9235205 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Lessa HA; Machado P; Lima F; Cruz AA; Bacellar O; Guerreiro J; Carvalho EM Am J Trop Med Hyg; 2001 Aug; 65(2):87-9. PubMed ID: 11508396 [TBL] [Abstract][Full Text] [Related]
6. Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases. Nateghi Rostami M; Seyyedan Jasbi E; Khamesipour A; Mohammadi AM Parasite Immunol; 2016 Apr; 38(4):255-60. PubMed ID: 26813918 [TBL] [Abstract][Full Text] [Related]
7. Immunopathology of American cutaneous leishmaniasis. Pirmez C Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():105-9. PubMed ID: 1342704 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Castes M; Trujillo D; Rojas ME; Fernandez CT; Araya L; Cabrera M; Blackwell J; Convit J Biol Res; 1993; 26(1-2):233-8. PubMed ID: 7670536 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of tumor necrosis factor-alpha (TNF-α), TNF-α soluble receptor type 1 (sTNFR I) and IL-22 in human leishmaniasis. Nateghi Rostami M; Seyyedan Jasbi E; Khamesipour A; Miramin Mohammadi A Trop Biomed; 2015 Sep; 32(3):478-84. PubMed ID: 26695208 [TBL] [Abstract][Full Text] [Related]
10. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Faria DR; Gollob KJ; Barbosa J; Schriefer A; Machado PR; Lessa H; Carvalho LP; Romano-Silva MA; de Jesus AR; Carvalho EM; Dutra WO Infect Immun; 2005 Dec; 73(12):7853-9. PubMed ID: 16299275 [TBL] [Abstract][Full Text] [Related]
11. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924 [TBL] [Abstract][Full Text] [Related]
12. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis. Machado PR; Lessa H; Lessa M; Guimarães LH; Bang H; Ho JL; Carvalho EM Clin Infect Dis; 2007 Mar; 44(6):788-93. PubMed ID: 17304449 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. Cabrera M; Shaw MA; Sharples C; Williams H; Castes M; Convit J; Blackwell JM J Exp Med; 1995 Nov; 182(5):1259-64. PubMed ID: 7595196 [TBL] [Abstract][Full Text] [Related]
14. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. Roessler K; Suchanek G; Breitschopf H; Kitz K; Matula C; Lassmann H; Koos WT J Neurosurg; 1995 Aug; 83(2):291-7. PubMed ID: 7616275 [TBL] [Abstract][Full Text] [Related]
16. Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Gaze ST; Dutra WO; Lessa M; Lessa H; Guimarães LH; Jesus AR; Carvalho LP; Machado P; Carvalho EM; Gollob KJ Scand J Immunol; 2006 Jan; 63(1):70-8. PubMed ID: 16398703 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha in human american tegumentary leishmaniasis. Da-Cruz AM; de Oliveira MP; De Luca PM; Mendonça SC; Coutinho SG Mem Inst Oswaldo Cruz; 1996; 91(2):225-9. PubMed ID: 8736095 [TBL] [Abstract][Full Text] [Related]
18. Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα. Nicodemo AC; Duailibi DF; Feriani D; Duarte MIS; Amato VS PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005807. PubMed ID: 28934199 [No Abstract] [Full Text] [Related]
19. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975 [TBL] [Abstract][Full Text] [Related]
20. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]